AKBA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Akebia Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.9666 USD 2.12% Market Closed

Market Cap: $259.3m

	Akebia Therapeutics Inc NASDAQ:AKBA	US
	Steven Madden Ltd F:SJM	US
	Vera Bradley Inc F:ELI	US
A	Allied Corp OTC:ALID	CA
	Aedifica NV XBRU:AED	BE
	GFL Environmental Inc F:36E	CA
	Descartes Systems Group Inc TSX:DSG	CA
C	CombinedX AB (publ) STO:CX	SE
M	MongoDB Inc F:526	US
	Newmark Group Inc NASDAQ:NMRK	US
P	Pecoy Copper Corp XTSX:PCU	CA

Profitability Summary

Akebia Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

82%

Strong 3Y Average Gross Margin

83%

Gross Margin is Increasing

80% > 82%

Negative Operating Margin

-3%

Negative 3Y Average Operating Margin

-10%

Operating Margin is Increasing

-46% > -3%

Negative Net Margin

-14%

Negative 3Y Average Net Margin

-21%

Net Margin is Increasing

-51% > -14%

Exceptional Free Cash Flow Margin

13%

Negative 3Y Average Free Cash Flow Margin

-7%

Free Cash Flow Margin is Increasing

-17% > 13%

Negative ROE

-109%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-8%

ROIC is Increasing

-34% > -3%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.